Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study
Journal of Cancer Survivorship · 2024-08 · 18 (4) · 1131-1143
DOI: 10.1007/s11764-024-01594-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 28.04.2024. Verfasst von Mina S Sedrak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. MSedrak@mednet.ucla.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCI NIH HHS, Conquer Cancer Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: This study aimed to assess whether physical functional decline in older women with early-stage breast cancer is driven by cancer, chemotherapy, or a combination of both. METHODS: We prospectively sampled three groups of women aged ≥ 65: 444 with early-stage breast cancer receiving chemotherapy (BC Chemo), 98 with early-stage breast cancer not receiving chemotherapy (BC Control), and 100 non-cancer controls (NC Control). Physical function was assessed at two timepoints (T1 [baseline] and T2 [3, 4, or 6 months]) using the Physical Functioning Subscale (PF-10) of the RAND 36-item Short Form. The primary endpoint was the change in PF-10 scores from T1 to T2, analyzed continuously and dichotomously (Yes/No, with "yes" indicating a PF-10 decline > 10 points, i.e., a substantial and clinically meaningful difference). RESULTS: Baseline PF-10 scores were similar across all groups. The BC Chemo group experienced a significant decline at T2, with a median change in PF-10 of -5 (interquartile range [IQR], -20, 0), while BC Control and NC Control groups showed a median change of 0 (IQR, -5, 5; p < 0.001). Over 30% of BC Chemo participants had a substantial decline in PF-10 vs. 8% in the BC Control and 5% in the NC Control groups (p < 0.001). CONCLUSION: In this cohort of older adults with early-stage breast cancer, the combination of breast cancer and chemotherapy contributes to accelerated functional decline. Our findings reinforce the need to develop interventions aimed at preserving physical function, particularly during and after chemotherapy. IMPLICATIONS FOR CANCER SURVIVORS: The high prevalence of accelerated functional decline in older women undergoing breast cancer chemotherapy underscores the urgency to develop interventions aimed at preserving physical function and improving health outcomes. CLINICAL TRIAL: NCT01472094, Hurria Older PatiEnts (HOPE) with Breast Cancer Study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. MSedrak@mednet.ucla.edu.
- Cancer & Aging Program, UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. MSedrak@mednet.ucla.edu.
- UCLA David Geffen School of Medicine, 650 Charles Young Drive South, Room A2-125 CHS, Los Angeles, CA, 90095-6900, USA. MSedrak@mednet.ucla.edu.
- Department of Supportive Care, City of Hope, Duarte, CA, USA.
- Center for Cancer and Aging, City of Hope, Duarte, CA, USA.
- Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA.
Förderung
- NIA NIH HHS
- NCI NIH HHS
- Conquer Cancer Foundation
- Susan G. Komen for the Cure
- NCATS NIH HHS
- American Cancer Society
- COH Cancer Control and Population Sciences Pilot Award
- Waisman Innovation Award
Zitieren
APA
Sedrak, M. S., Sun, C. L., Bae, M., Freedman, R. A., Magnuson, A., O'Connor, T., Moy, B., Wildes, T. M., Klepin, H. D., Chapman, A. E., Tew, W. P., Dotan, E., Fenton, M. A., Kim, H., Katheria, V., Muss, H. B., Cohen, H. J., Gross, C. P., & Ji, J. (2024). Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal of Cancer Survivorship, 18(4), 1131-1143. https://doi.org/10.1007/s11764-024-01594-3
Vancouver
Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, et al. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal of Cancer Survivorship. 2024;18(4):1131-1143. doi:10.1007/s11764-024-01594-3
BibTeX
@article{Sedrak2024,
author = {Sedrak, Mina S and Sun, Can-Lan and Bae, Marie and Freedman, Rachel A and Magnuson, Allison and O'Connor, Tracey and Moy, Beverly and Wildes, Tanya M and Klepin, Heidi D and Chapman, Andrew E and Tew, William P and Dotan, Efrat and Fenton, Mary Anne and Kim, Heeyoung and Katheria, Vani and Muss, Hyman B and Cohen, Harvey J and Gross, Cary P and Ji, Jingran},
title = {Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study},
journal = {Journal of Cancer Survivorship},
year = {2024},
volume = {18},
number = {4},
pages = {1131--1143},
doi = {10.1007/s11764-024-01594-3}
}
EUVIMED